- Launchpad Venture Group is an angel investment group that invested $7 million in 45 portfolio companies in 2013, including 12 new deals and 16 follow-on deals. The group focuses on exits and bringing experience to portfolio companies.
- The environment for life sciences funding has changed, with large biopharma moving to Boston, venture capital focusing on earlier stages, and fewer federal grants available. This has created opportunities for angel groups.
- Dr. Richard Gill serves as a board director and investor for Launchpad Venture Group, with a focus on exits and ensuring return on investment exceeds what was invested. He has had successful exits from portfolio companies.